Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non Small Cell Lung Cancer Stage”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02166242
What this trial is testing

Ethaselen for the Treatment of Thioredoxin Reductase High Expression Advanced Non-small Cell Lung Cancers

Who this might be right for
Carcinoma, Non-small Cell Lung
Hunan Province Tumor Hospital 40
Testing effectiveness (Phase 2)Ended earlyNCT02382406
What this trial is testing

Carboplatin/Nab-Paclitaxel and Pembrolizumab in NSCLC

Who this might be right for
Non-Small Cell Lung Cancer
Nisha Mohindra, MD 46
Large-scale testing (Phase 3)Active Not RecruitingNCT04547504
What this trial is testing

PEmbRolizumab verSus chEmotherapy and pEmbrolizumab in Non-small-cell Lung Cancers (NSCLC) With PDL1 ≥ 50 %

Who this might be right for
Non-small-cell Lung Cancer
University Hospital, Brest 349
Early research (Phase 1)Looking for participantsNCT06066138
What this trial is testing

Therapeutic Drug Monitoring-Based Atezolizumab Dosing

Who this might be right for
Locally Advanced Alveolar Soft Part SarcomaMetastatic Alveolar Soft Part SarcomaLocally Advanced Non Small Cell Lung Cancer+7 more
National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Study completedNCT01858389
What this trial is testing

Dacomitinib (PF-00299804) In Patients With Advanced Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Pfizer 41
Testing effectiveness (Phase 2)Looking for participantsNCT05613452
What this trial is testing

Carbon Ion Therapy for Peripheral Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Shanghai Proton and Heavy Ion Center 43
Early research (Phase 1)Study completedNCT02197247
What this trial is testing

Study to Assess the Effect of Rifampicin on Blood Levels and Safety of AZD9291, in Patients With EGFRm+ NSCLC

Who this might be right for
Non Small Cell Lung Cancer
AstraZeneca 41
Large-scale testing (Phase 3)Study completedNCT00622349
What this trial is testing

Randomised Study Comparing Three Chemotherapy Regimens in Non-small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
European Lung Cancer Working Party 707
Testing effectiveness (Phase 2)Study completedNCT00089726
What this trial is testing

A Cancer Vaccine (CG8123) Given With and Without Cyclophosphamide for Advanced Stage Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Lung CancerCarcinoma, Non-Small-Cell Lung
Cell Genesys 100
Not applicableUnknownNCT04984148
What this trial is testing

Construction of CT Radiomics Model for Predicting the Efficacy of Immunotherapy in Patients With Stage III NSCLC

Who this might be right for
Stage III Non-small Cell Lung Cancer
Guangdong Provincial People's Hospital 70
Large-scale testing (Phase 3)UnknownNCT03402048
What this trial is testing

The EPIC Trial The Elderly Patient Individualized Chemotherapy Trial

Who this might be right for
Stage IV, NSCLCLung NeoplasmsBronchial Neoplasms+6 more
University of Turin, Italy 567
Testing effectiveness (Phase 2)UnknownNCT04675008
What this trial is testing

Central Nervous System(CNS) Efficacy of Dacomitinib

Who this might be right for
Non Small Cell Lung CancerBrain Metastases
Samsung Medical Center 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06908733
What this trial is testing

Integrating Surgery and Radiotherapy Following Tislelizumab-based Conversion Therapy in N3-Stage III NSCLC

Who this might be right for
Non-Small Cell Lung Cancer (Stage III)
Liaoning Cancer Hospital & Institute 30
Early research (Phase 1)Study completedNCT03812549
What this trial is testing

Safety and Tolerability Evaluation of Sintilimab in Combination With Radiation in Stage IV NSCLC Patients

Who this might be right for
Stage IV NSCLC
Sichuan University 29
Early research (Phase 1)Study completedNCT01478685
What this trial is testing

CC-486 as a Single Agent and in Combination With Carboplatin or ABI-007 in Subjects With Relapsed or Refractory Solid Tumors

Who this might be right for
Urinary Bladder NeoplasmsCarcinoma, Transitional CellOvarian Neoplasms+5 more
Celgene 169
Early research (Phase 1)Looking for participantsNCT06596915
What this trial is testing

Safety and Efficacy of BA1302 in Patients With Advanced Solid Tumors

Who this might be right for
Non-Small Cell Lung CancerPancreatic AdenocarcinomaBreast Cancer+1 more
Shandong Boan Biotechnology Co., Ltd 167
Early research (Phase 1)Study completedNCT04879849
What this trial is testing

TAK-676 With Pembrolizumab After Radiation Therapy to Treat a Number of Cancers

Who this might be right for
Carcinoma, Non-Small-Cell LungTriple Negative Breast NeoplasmsSquamous Cell Carcinoma of Head and Neck
Takeda 34
Testing effectiveness (Phase 2)Study completedNCT03573947
What this trial is testing

Phase II Clinical Trial of NIVO-IPI-TAXANE in Untreated Metastatic NSCLC

Who this might be right for
Non-small Cell Lung Cancer
Jeffrey Clarke 46
Testing effectiveness (Phase 2)Ended earlyNCT02485652
What this trial is testing

Phase II Trial of HM61713 for the Treatment of ≥2nd Line T790M Mutation Positive Adenocarcinoma of the Lung

Who this might be right for
Non Small Cell Lung Cancer
Hanmi Pharmaceutical Company Limited 162
Early research (Phase 1)Ended earlyNCT03054038
What this trial is testing

Afatinib and Necitumumab in Patients With EGFR Mutation Positive Advanced or Metastatic Non-small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Carcinoma
Vanderbilt-Ingram Cancer Center 22
Next Page